Lower-cost transactional solutions with strategic resourcing and innovative technologies.
Integrated services that cover planning, management, execution and analysis.
Insight on strategies and execution for long-term value to maximise success.
Global experience in all Phases of oncology drug development.
Experience in cardiovascular trials supported by a global team of experts.
ICON has conducted diabetes trials in all global regions.
ICON and IBM are working together to revolutionise clinical trial feasibility and patient recruitment.
Designed to enhance patient engagement and support patient recruitment and retention.
Using data to design, simulate, and analyse adaptive clinical trials with ease.
The traditional clinical development model needs to change.
Understand and successfully address the complexities of adaptive trial design.
ICON sponsored research outlines partnership strategies to optimise clinical development.
2 - 6 JuneMeeting of global oncology professionals to discuss the latest trends in cancer care treatments
7 - 8 JuneForging clinical trial partnerships that drive innovation
18 - 22 JuneSharing insights and driving action in health care at DIA 2017 Global Annual Meeting
From a small team of 5 people in 1990, ICON now employs over 12,300 professionals in 38 countries.
We are committed to exceeding the quality standards demanded by our clients, patients and regulatory authorities.
Local knowledge combined with global expertise to ensure quality data on time and within budget.
ICON has assembled a leadership team with unrivaled vision and experience.